Novartis AG (LON:0K9E)

Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of GBP 184.93 billion. The enterprise value is 202.09 billion.

Market Cap	184.93B
Enterprise Value	202.09B

Important Dates

The last earnings date was Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	Mar 12, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.84%
Shares Change (QoQ)	-1.02%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	37.42%
Float	1.83B

Valuation Ratios

The trailing PE ratio is 17.27 and the forward PE ratio is 14.56.

PE Ratio	17.27
Forward PE	14.56
PS Ratio	4.41
PB Ratio	5.55
P/TBV Ratio	n/a
P/FCF Ratio	12.70
P/OCF Ratio	11.80
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.65, with an EV/FCF ratio of 13.88.

EV / Earnings	18.87
EV / Sales	4.76
EV / EBITDA	10.65
EV / EBIT	13.12
EV / FCF	13.88

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.72.

Current Ratio	0.88
Quick Ratio	0.58
Debt / Equity	0.72
Debt / EBITDA	1.27
Debt / FCF	1.64
Interest Coverage	18.35

Financial Efficiency

Return on equity (ROE) is 32.62% and return on invested capital (ROIC) is 16.78%.

Return on Equity (ROE)	32.62%
Return on Assets (ROA)	12.13%
Return on Invested Capital (ROIC)	16.78%
Return on Capital Employed (ROCE)	27.17%
Revenue Per Employee	552,659
Profits Per Employee	141,106
Employee Count	75,883
Asset Turnover	0.53
Inventory Turnover	2.17

Taxes

In the past 12 months, Novartis AG has paid 1.51 billion in taxes.

Income Tax	1.51B
Effective Tax Rate	12.40%

Stock Price Statistics

The stock price has increased by +18.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+18.17%
50-Day Moving Average	127.31
200-Day Moving Average	117.02
Relative Strength Index (RSI)	49.19
Average Volume (20 Days)	10,934

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of GBP 41.94 billion and earned 10.71 billion in profits. Earnings per share was 5.43.

Revenue	41.94B
Gross Profit	31.98B
Operating Income	15.22B
Pretax Income	12.21B
Net Income	10.71B
EBITDA	18.54B
EBIT	15.22B
Earnings Per Share (EPS)	5.43

Balance Sheet

The company has 7.19 billion in cash and 23.82 billion in debt, giving a net cash position of -16.63 billion.

Cash & Cash Equivalents	7.19B
Total Debt	23.82B
Net Cash	-16.63B
Net Cash Per Share	n/a
Equity (Book Value)	33.29B
Book Value Per Share	17.19
Working Capital	-2.83B

Cash Flow

In the last 12 months, operating cash flow was 15.68 billion and capital expenditures -1.11 billion, giving a free cash flow of 14.56 billion.

Operating Cash Flow	15.68B
Capital Expenditures	-1.11B
Free Cash Flow	14.56B
FCF Per Share	n/a

Margins

Gross margin is 76.25%, with operating and profit margins of 36.29% and 25.53%.

Gross Margin	76.25%
Operating Margin	36.29%
Pretax Margin	29.13%
Profit Margin	25.53%
EBITDA Margin	44.21%
EBIT Margin	36.29%
FCF Margin	34.73%

Dividends & Yields

This stock pays an annual dividend of 2.61, which amounts to a dividend yield of 2.09%.

Dividend Per Share	2.61
Dividend Yield	2.09%
Dividend Growth (YoY)	5.34%
Years of Dividend Growth	3
Payout Ratio	54.32%
Buyback Yield	3.84%
Shareholder Yield	5.93%
Earnings Yield	5.79%
FCF Yield	7.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.8 and a Piotroski F-Score of 7.

Altman Z-Score	3.8
Piotroski F-Score	7